APO RESEARCH · REPORT
In Vitro Diagnostic (IVD) Reagents
In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.
Product & engineering
Understand the product.
In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.
Selected research
Industry Research
In Vitro Diagnostic (IVD) Reagents Industry Research Report 2026
Market perspective
In vitro diagnosis includes two parts: diagnostic instrument and diagnostic reagent.In vitro diagnostic instruments belong to the clinical test analysis instruments under the secondary classification of medical devices, while diagnostic reagents belong to the biological products of biomedical products.The downstream application market of diagnostic reagent is mainly hospitals and laboratories.Among them, hospitals account for the major part. In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.
Global In Vitro Diagnostic (IVD) Reagents key players include Roche, Danaher, Sysmex Corporation, Mindray Medical, etc. Global top four manufacturers hold a share over 20%.
North America is the largest market, with a share about 40%, followed by Europe, and Japan, both have a share over 35 percent.
Read the full market overview
In terms of product, POCT is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital, followed by Laboratory, etc.
Report Scope
This report quantifies the global In Vitro Diagnostic (IVD) Reagents market in terms of revenue (US$ million) and, where applicable, sales volume (Million Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Million Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In Vitro Diagnostic (IVD) Reagents Market by Company
Roche
Danaher
Abbott Laboratories
Thermal Fisher
Sysmex Corporation
Biomerieux
Siemens
Ortho Clinical Diagnostics
BD
Bio-Rad
Myriad Genetics
Hologic
QIAGEN
Mindray Medical
Wondfo
KHB
Da An Gene
Leadman
Biosino
In Vitro Diagnostic (IVD) Reagents Segment by Type
Immune Diagnosis
Clinical and Biochemical
Molecular Diagnosis
POCT
Other
In Vitro Diagnostic (IVD) Reagents Segment by Application
Hospital
Laboratory
Other
In Vitro Diagnostic (IVD) Reagents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic (IVD) Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic (IVD) Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic (IVD) Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of In Vitro Diagnostic (IVD) Reagents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of In Vitro Diagnostic (IVD) Reagents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of In Vitro Diagnostic (IVD) Reagents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immune Diagnosis
- Clinical and Biochemical
- Molecular Diagnosis
- POCT
- Other
Applications
- Hospital
- Laboratory
- Other
Companies covered
- Roche
- Danaher
- Abbott Laboratories
- Thermal Fisher
- Sysmex Corporation
- Biomerieux
- Siemens
- Ortho Clinical Diagnostics
- BD
- Bio-Rad
- Myriad Genetics
- Hologic
- QIAGEN
- Mindray Medical
- Wondfo
- KHB
- Da An Gene
- Leadman
- Biosino
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global In Vitro Diagnostic (IVD) Reagents Market Size (2021-2032)
- 2.2.2 Global In Vitro Diagnostic (IVD) Reagents Sales (2021-2032)
- 2.2.3 Global In Vitro Diagnostic (IVD) Reagents Market Average Price (2021-2032)
- 2.3 In Vitro Diagnostic (IVD) Reagents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Immune Diagnosis
- 2.3.3 Clinical and Biochemical
- 2.3.4 Molecular Diagnosis
- 2.3.5 POCT
- 2.3.6 Other
- 2.4 In Vitro Diagnostic (IVD) Reagents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Laboratory
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global In Vitro Diagnostic (IVD) Reagents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global In Vitro Diagnostic (IVD) Reagents Sales (Million Units) of Manufacturers (2021-2026)
- 3.3 Global In Vitro Diagnostic (IVD) Reagents Revenue of Manufacturers (2021-2026)
- 3.4 Global In Vitro Diagnostic (IVD) Reagents Average Price by Manufacturers (2021-2026)
- 3.5 Global In Vitro Diagnostic (IVD) Reagents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of In Vitro Diagnostic (IVD) Reagents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of In Vitro Diagnostic (IVD) Reagents, Product Type & Application
- 3.8 Global Manufacturers of In Vitro Diagnostic (IVD) Reagents, Established Date
- 3.9 Global In Vitro Diagnostic (IVD) Reagents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Danaher
- 4.2.1 Danaher Company Information
- 4.2.2 Danaher Business Overview
- 4.2.3 Danaher In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Danaher In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.2.5 Danaher Recent Developments
- 4.3 Abbott Laboratories
- 4.3.1 Abbott Laboratories Company Information
- 4.3.2 Abbott Laboratories Business Overview
- 4.3.3 Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.3.5 Abbott Laboratories Recent Developments
- 4.4 Thermal Fisher
- 4.4.1 Thermal Fisher Company Information
- 4.4.2 Thermal Fisher Business Overview
- 4.4.3 Thermal Fisher In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Thermal Fisher In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.4.5 Thermal Fisher Recent Developments
- 4.5 Sysmex Corporation
- 4.5.1 Sysmex Corporation Company Information
- 4.5.2 Sysmex Corporation Business Overview
- 4.5.3 Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.5.5 Sysmex Corporation Recent Developments
- 4.6 Biomerieux
- 4.6.1 Biomerieux Company Information
- 4.6.2 Biomerieux Business Overview
- 4.6.3 Biomerieux In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Biomerieux In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.6.5 Biomerieux Recent Developments
- 4.7 Siemens
- 4.7.1 Siemens Company Information
- 4.7.2 Siemens Business Overview
- 4.7.3 Siemens In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Siemens In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.7.5 Siemens Recent Developments
- 4.8 Ortho Clinical Diagnostics
- 4.8.1 Ortho Clinical Diagnostics Company Information
- 4.8.2 Ortho Clinical Diagnostics Business Overview
- 4.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.8.5 Ortho Clinical Diagnostics Recent Developments
- 4.9 BD
- 4.9.1 BD Company Information
- 4.9.2 BD Business Overview
- 4.9.3 BD In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BD In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.9.5 BD Recent Developments
- 4.10 Bio-Rad
- 4.10.1 Bio-Rad Company Information
- 4.10.2 Bio-Rad Business Overview
- 4.10.3 Bio-Rad In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bio-Rad In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.10.5 Bio-Rad Recent Developments
- 4.11 Myriad Genetics
- 4.11.1 Myriad Genetics Company Information
- 4.11.2 Myriad Genetics Business Overview
- 4.11.3 Myriad Genetics In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Myriad Genetics In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.11.5 Myriad Genetics Recent Developments
- 4.12 Hologic
- 4.12.1 Hologic Company Information
- 4.12.2 Hologic Business Overview
- 4.12.3 Hologic In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hologic In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.12.5 Hologic Recent Developments
- 4.13 QIAGEN
- 4.13.1 QIAGEN Company Information
- 4.13.2 QIAGEN Business Overview
- 4.13.3 QIAGEN In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 QIAGEN In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.13.5 QIAGEN Recent Developments
- 4.14 Mindray Medical
- 4.14.1 Mindray Medical Company Information
- 4.14.2 Mindray Medical Business Overview
- 4.14.3 Mindray Medical In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Mindray Medical In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.14.5 Mindray Medical Recent Developments
- 4.15 Wondfo
- 4.15.1 Wondfo Company Information
- 4.15.2 Wondfo Business Overview
- 4.15.3 Wondfo In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Wondfo In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.15.5 Wondfo Recent Developments
- 4.16 KHB
- 4.16.1 KHB Company Information
- 4.16.2 KHB Business Overview
- 4.16.3 KHB In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 KHB In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.16.5 KHB Recent Developments
- 4.17 Da An Gene
- 4.17.1 Da An Gene Company Information
- 4.17.2 Da An Gene Business Overview
- 4.17.3 Da An Gene In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Da An Gene In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.17.5 Da An Gene Recent Developments
- 4.18 Leadman
- 4.18.1 Leadman Company Information
- 4.18.2 Leadman Business Overview
- 4.18.3 Leadman In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Leadman In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.18.5 Leadman Recent Developments
- 4.19 Biosino
- 4.19.1 Biosino Company Information
- 4.19.2 Biosino Business Overview
- 4.19.3 Biosino In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Biosino In Vitro Diagnostic (IVD) Reagents Product Portfolio
- 4.19.5 Biosino Recent Developments
5 Global In Vitro Diagnostic (IVD) Reagents Market Scenario by Region
- 5.1 Global In Vitro Diagnostic (IVD) Reagents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2021-2032
- 5.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2021-2026
- 5.2.2 Global In Vitro Diagnostic (IVD) Reagents Sales by Region: 2027-2032
- 5.3 Global In Vitro Diagnostic (IVD) Reagents Revenue by Region: 2021-2032
- 5.3.1 Global In Vitro Diagnostic (IVD) Reagents Revenue by Region: 2021-2026
- 5.3.2 Global In Vitro Diagnostic (IVD) Reagents Revenue by Region: 2027-2032
- 5.4 North America In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
- 5.4.1 North America In Vitro Diagnostic (IVD) Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2032)
- 5.4.3 North America In Vitro Diagnostic (IVD) Reagents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
- 5.5.1 Europe In Vitro Diagnostic (IVD) Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2032)
- 5.5.3 Europe In Vitro Diagnostic (IVD) Reagents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
- 5.6.1 Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific In Vitro Diagnostic (IVD) Reagents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
- 5.7.1 South America In Vitro Diagnostic (IVD) Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2032)
- 5.7.3 South America In Vitro Diagnostic (IVD) Reagents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Type (2021-2032)
- 6.1.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Type (2021-2032) & (Million Units)
- 6.1.2 Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Type (2021-2032)
- 6.2 Global In Vitro Diagnostic (IVD) Reagents Revenue by Type (2021-2032)
- 6.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Type (2021-2032)
- 6.3 Global In Vitro Diagnostic (IVD) Reagents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Application (2021-2032)
- 7.1.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Application (2021-2032) & (Million Units)
- 7.1.2 Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Application (2021-2032)
- 7.2 Global In Vitro Diagnostic (IVD) Reagents Revenue by Application (2021-2032)
- 7.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Application (2021-2032)
- 7.3 Global In Vitro Diagnostic (IVD) Reagents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 In Vitro Diagnostic (IVD) Reagents Value Chain Analysis
- 8.1.1 In Vitro Diagnostic (IVD) Reagents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 In Vitro Diagnostic (IVD) Reagents Production Mode & Process
- 8.2 In Vitro Diagnostic (IVD) Reagents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 In Vitro Diagnostic (IVD) Reagents Distributors
- 8.2.3 In Vitro Diagnostic (IVD) Reagents Customers
9 Global In Vitro Diagnostic (IVD) Reagents Analyzing Market Dynamics
- 9.1 In Vitro Diagnostic (IVD) Reagents Industry Trends
- 9.2 In Vitro Diagnostic (IVD) Reagents Industry Drivers
- 9.3 In Vitro Diagnostic (IVD) Reagents Industry Opportunities and Challenges
- 9.4 In Vitro Diagnostic (IVD) Reagents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst